Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lichtenstein

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
Journal of Virology|September 5, 2001
Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteinsA E Tollefson, K Toth, K Doronin, et al.
Human Gene Therapy|February 11, 2005
Cotton rat tumor model for the evaluation of oncolytic adenovirusesKaroly Toth, Jacqueline F Spencer, Ann E Tollefson, et al.
JCO Oncology Practice|December 6, 2022
Impact of a Hospital-Based Specialty Pharmacy in Partnership With a Care Coordination Organization on Time to Delivery and Receipt of Oral Anticancer DrugsMelissa P Beauchemin, Morgan R L Lichtenstein, Rohit Raghunathan, et al.
JAMA Network Open|October 13, 2022
Factors Associated With Patients Not Receiving Oral Anticancer DrugsSahil D Doshi, Morgan R L Lichtenstein, Melissa P Beauchemin, et al.
Cancer|March 7, 2020
Performance status and end-of-life care among adults with non-small cell lung cancer receiving immune checkpoint inhibitorsLaura A Petrillo, Areej El-Jawahri, Ryan D Nipp, et al.
Nature|May 16, 1998
Forced degradation of Fas inhibits apoptosis in adenovirus-infected cellsA E Tollefson, T W Hermiston, D L Lichtenstein, et al.
JCO Oncology Practice|November 30, 2023
Association Between Copayment Assistance, Insurance Type, Prior Authorization, and Time to Receipt of Oral Anticancer DrugsMorgan R L Lichtenstein, Melissa P Beauchemin, Rohit Raghunathan, et al.
Medical Care|August 1, 1995
Diagnosis-related group refinement with diagnosis- and procedure-specific comorbidities and complicationsJ L Freeman, R B Fetter, H Park, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|November 17, 2025
Self-Efficacy Change among Diverse Family Caregivers in Dementia CareDeborah M Oyeyemi, Erich J Greene, Yunshan Xu, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
Medical Multimorbidity in Patients with Treatment-Resistant Psychosis and Rare Copy Number Variants: A Retrospective Case Series of 24 PatientsTyler E Dietterich, Rose Mary Xavier, Maya L Lichtenstein, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
Journal of Virology|September 5, 2001
Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteinsA E Tollefson, K Toth, K Doronin, et al.
Human Gene Therapy|February 11, 2005
Cotton rat tumor model for the evaluation of oncolytic adenovirusesKaroly Toth, Jacqueline F Spencer, Ann E Tollefson, et al.
JCO Oncology Practice|December 6, 2022
Impact of a Hospital-Based Specialty Pharmacy in Partnership With a Care Coordination Organization on Time to Delivery and Receipt of Oral Anticancer DrugsMelissa P Beauchemin, Morgan R L Lichtenstein, Rohit Raghunathan, et al.
JAMA Network Open|October 13, 2022
Factors Associated With Patients Not Receiving Oral Anticancer DrugsSahil D Doshi, Morgan R L Lichtenstein, Melissa P Beauchemin, et al.
Cancer|March 7, 2020
Performance status and end-of-life care among adults with non-small cell lung cancer receiving immune checkpoint inhibitorsLaura A Petrillo, Areej El-Jawahri, Ryan D Nipp, et al.
Nature|May 16, 1998
Forced degradation of Fas inhibits apoptosis in adenovirus-infected cellsA E Tollefson, T W Hermiston, D L Lichtenstein, et al.
JCO Oncology Practice|November 30, 2023
Association Between Copayment Assistance, Insurance Type, Prior Authorization, and Time to Receipt of Oral Anticancer DrugsMorgan R L Lichtenstein, Melissa P Beauchemin, Rohit Raghunathan, et al.
Medical Care|August 1, 1995
Diagnosis-related group refinement with diagnosis- and procedure-specific comorbidities and complicationsJ L Freeman, R B Fetter, H Park, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|November 17, 2025
Self-Efficacy Change among Diverse Family Caregivers in Dementia CareDeborah M Oyeyemi, Erich J Greene, Yunshan Xu, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
Medical Multimorbidity in Patients with Treatment-Resistant Psychosis and Rare Copy Number Variants: A Retrospective Case Series of 24 PatientsTyler E Dietterich, Rose Mary Xavier, Maya L Lichtenstein, et al.
Pageof 17